FCRL6 and neoplasm: Consistent with the known responsiveness of these tumors to ICI therapy and the TIL concentrations in the tumor microenvironment (75–82), these findings indicate that elevated FCRL6 expression confers a generally favorable prognosis for the OS of patients with these tumors.